We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+71.21%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$491M
AUM Growth
+$188M
Cap. Flow
+$45.5M
Cap. Flow %
9.28%
Top 10 Hldgs %
18.99%
Holding
156
New
44
Increased
44
Reduced
29
Closed
39

Top Buys

Rank Stock Value
1
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$7.26M
2
OLLI icon
Ollie's Bargain Outlet
OLLI
+$6.35M
3
CDNA icon
CareDx
CDNA
+$6.35M
4
NET icon
Cloudflare
NET
+$5.7M
5
LSCC icon
Lattice Semiconductor
LSCC
+$5.59M

Top Sells

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$9.22M
2
FCN icon
FTI Consulting
FCN
+$6.26M
3
ITRI icon
Itron
ITRI
+$6.25M
4
RGEN icon
Repligen
RGEN
+$6.07M
5
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
+$5.44M

Sector Composition

Rank Sector Weight
1 Healthcare 23.1%
2 Technology 22.24%
3 Industrials 19.83%
4 Consumer Discretionary 16.89%
5 Financials 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
101
Alnylam Pharmaceuticals
ALNY
$32.3B
$1.38M 0.28%
9,285
+4,031
+77% +$543K
AVLR
102
DELISTED
Avalara, Inc.
AVLR
$1.29M 0.26%
9,665
-50,262
-84% -$4.94M
KPTI icon
103
Karyopharm Therapeutics
KPTI
$37.7M
$1.24M 0.25%
4,371
-4,568
-51% -$1.35M
POOL icon
104
Pool Corp
POOL
$6.21B
$1.23M 0.25%
4,520
-7,801
-63% -$1.81M
CRWD icon
105
CrowdStrike
CRWD
$249B
$1.22M 0.25%
48,680
-147,920
-75% -$2.97M
CRL icon
106
Charles River Laboratories
CRL
$13.4B
$1.14M 0.23%
+6,535
New +$1.04M
CHWY icon
107
Chewy
CHWY
$8.52B
$1.08M 0.22%
24,155
-25,779
-52% -$1.12M
PPD
108
DELISTED
PPD, Inc. Common Stock
PPD
$1.07M 0.22%
40,075
+4,535
+13% +$113K
OKTA icon
109
Okta
OKTA
$33.1B
$1.03M 0.21%
+5,170
New +$878K
EEFT icon
110
Euronet Worldwide
EEFT
$2.6B
$989K 0.2%
10,320
+3,600
+54% +$333K
SIBN icon
111
SI-BONE Inc
SIBN
$836M
$944K 0.19%
+59,234
New +$934K
MKSI icon
112
MKS Inc
MKSI
$16B
$836K 0.17%
+7,380
New +$734K
ZEN
113
DELISTED
ZENDESK INC
ZEN
$814K 0.17%
9,195
+3,040
+49% +$234K
COUP
114
DELISTED
Coupa Software Incorporated
COUP
$762K 0.16%
2,750
-20,736
-88% -$4.18M
GTM
115
ZoomInfo Technologies
GTM
$1.19B
$662K 0.13%
+12,975
New +$620K
CGNX icon
116
Cognex
CGNX
$10.2B
$544K 0.11%
+9,115
New +$495K
IWO icon
117
iShares Russell 2000 Growth ETF
IWO
$14.2B
$233K 0.05%
+1,125
New +$210K
ACA icon
118
Arcosa
ACA
$7.14B
– –
-99,050
Closed -$3.94M
APLS
119
DELISTED
Apellis Pharmaceuticals
APLS
– –
-28,350
Closed -$759K
CHGG icon
120
Chegg
CHGG
$82.3M
– –
-88,015
Closed -$3.15M
CLH icon
121
Clean Harbors
CLH
$16.9B
– –
-34,860
Closed -$1.79M
CRSP icon
122
CRISPR Therapeutics
CRSP
$5.12B
– –
-16,690
Closed -$708K
CSGP icon
123
CoStar Group
CSGP
$12.5B
– –
-15,610
Closed -$917K
DOCU
124
DocuSign
DOCU
$13.3B
– –
-16,935
Closed -$1.56M
DXCM icon
125
DexCom
DXCM
$33.3B
– –
-22,144
Closed -$1.49M
3 4
5
6 7

Similar funds

HFA
Highland Financial Advisors Wayne, New Jersey $455M AUM 22.51% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return
PIM
Progressive Investment Management Lake Oswego, Oregon $454M AUM 46.56% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $454M AUM 28.38% 1-Year Est. Return
MI
Markowski Investments Tampa, Florida $454M AUM
MC
Miramar Capital Northbrook, Illinois $455M AUM 15.58% 1-Year Est. Return
CFO
Colony Family Offices Charlotte, North Carolina $455M AUM 21.83% 1-Year Est. Return
IIA
Integral Investment Advisors Turlock, California $454M AUM 21.42% 1-Year Est. Return

Lisanti Capital Growth's Q2 2020 Portfolio in Review

As of Q2 2020, Lisanti Capital Growth held 156 positions worth $491M, up 62% from $303M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth deployed $45.5M of net new capital in Q2 2020, opening 44 new positions and adding to 44 existing holdings. Its largest new stake was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was FIVE9, an estimated $9.22M trimmed.

  • Lisanti Capital Growth's largest Q2 2020 buy was Livongo Health, Inc. Common Stock: 138,705 shares worth $10.4M.
  • Lisanti Capital Growth added most to Patrick Industries in Q2 2020, an estimated $4.65M increase.
  • Lisanti Capital Growth's biggest Q2 2020 reduction was FIVE9, cutting an estimated $9.22M.
  • Lisanti Capital Growth fully exited FTI Consulting in Q2 2020, selling an estimated $6.26M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $491M portfolio in Q2 2020.
  • Lisanti Capital Growth opened 44 new positions and closed 39 in Q2 2020.
  • Lisanti Capital Growth's portfolio value rose 62% quarter-over-quarter to $491M.

Based on Lisanti Capital Growth's 13F filing for Q2 2020, filed 10 Aug 2020.